227 related articles for article (PubMed ID: 9102221)
21. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
22. Endothelial progenitor cells as putative targets for angiostatin.
Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
[TBL] [Abstract][Full Text] [Related]
23. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
24. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
25. Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer.
Wilczyńska U; Kucharska A; Szary J; Szala S
Acta Biochim Pol; 2001; 48(4):1077-84. PubMed ID: 11995969
[TBL] [Abstract][Full Text] [Related]
26. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
27. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.
Xin L; Xu R; Zhang Q; Li TP; Gan RB
Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661
[TBL] [Abstract][Full Text] [Related]
28. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.
Galaup A; Magnon C; Rouffiac V; Opolon P; Opolon D; Lassau N; Tursz T; Perricaudet M; Griscelli F
Gene Ther; 2005 May; 12(10):831-42. PubMed ID: 15789064
[TBL] [Abstract][Full Text] [Related]
29. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
Gorrin-Rivas MJ; Arii S; Furutani M; Mizumoto M; Mori A; Hanaki K; Maeda M; Furuyama H; Kondo Y; Imamura M
Clin Cancer Res; 2000 May; 6(5):1647-54. PubMed ID: 10815882
[TBL] [Abstract][Full Text] [Related]
30. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Yang H; Akor C; Dithmar S; Grossniklaus HE
Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumor growth by plasminogen-related protein-B.
Lewis VO; O'Reilly MS; Gehrmann M; Llinás M; Schaller J; Weissbach L
Anticancer Res; 2001; 21(4A):2287-91. PubMed ID: 11724284
[TBL] [Abstract][Full Text] [Related]
32. [Expression and characterization of Kringle 1-4.5 domains of human plasminogen].
Zhou QW; Xie JL; Xin L; Xu R; Ye Q; Li ZP; Gan RB
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):138-42. PubMed ID: 12545220
[TBL] [Abstract][Full Text] [Related]
33. Expression and activity determination of human angiostatin (k1-3) in culture cells and larvae of silkworm.
Wang YF; Jin YF; Zhang YZ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):482-7. PubMed ID: 12098772
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
Cornelius LA; Nehring LC; Harding E; Bolanowski M; Welgus HG; Kobayashi DK; Pierce RA; Shapiro SD
J Immunol; 1998 Dec; 161(12):6845-52. PubMed ID: 9862716
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
36. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
Pozzi A; LeVine WF; Gardner HA
Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
[TBL] [Abstract][Full Text] [Related]
37. Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS
Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539
[TBL] [Abstract][Full Text] [Related]
38. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
[TBL] [Abstract][Full Text] [Related]
39. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
40. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]